Public Companies
Believing you took ketamine during surgery has antidepressant effects: Stanford Medicine study
All participants in the placebo group reported a 50 per cent drop in depression symptoms after surgery
The post Believing you took ketamine during surgery…
Read more: PharmaTher Holdings enters collaboration to commercialize racemic ketamine Read more: Psycheceutical Bioscience develops non-psychoactive ketamine topical for PTSD and depressionThanks you Nina Bai @StanfordMed for the writeup of our study! out today in @NatMentHealth "Randomized trial of ketamine masked by surgical anesthesia in patients with depression"https://t.co/1AEUCtoGgg
— Boris D Heifets (@TheBorisLab) October 19, 2023
Researchers found results to be surprising
The researchers say those who reported the most significant improvements in their depression symptoms were more likely to believe they took ketamine, even when they didn’t.“It’s like looking at a Picasso painting,” said Schatzberg.“To put that into perspective, that brings them down to a category of mild depression from what had been debilitating levels of depression,” added Lii. Depression can worsen after surgery among many individuals, which made the scholars conclude that the surgeries and anesthesia were unlikely responsible for the participants’ improvements. The investigators said that the results may have been affected by the participants’ favourable view of ketamine and its recent popularity in helping with depression. “Maybe with a non-hallucinogenic psychedelic analogue you can get the same benefits without having to, you know, go to outer space,” Heifets added. Read more: EntheoTech Bioscience opens flagship ketamine clinic in Kelowna Read more: Awakn set to research ketamine for alcohol use disorder Ketamine has been gaining interest within the medical community in recent days for its potential to treat depression and an assortment of conditions. Ketamine therapy utilizing lozenges or intravenous administration has become a popular treatment option and business for different companies in Canada, many American states and abroad in recent years. Some, like Psycheceutical Bioscience Inc (OTC: BWVI), have even found ways to administer it without any psychoactive effects while retaining its therapeutic benefits through the use of a topical applied to the back of the neck. Others like the United Kingdom’s Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) have been studying the drug’s potential for the treatment of alcohol use disorder.
rowan@mugglehead.com
The post Believing you took ketamine during surgery has antidepressant effects: Stanford Medicine study appeared first on Mugglehead Magazine. ketamine psychiatry psychedelic psychoactive therapy depression antidepressant ptsd hallucinogenic otc pharmather awakn life sciences awakn research-
Psychedelics1 week ago
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
-
Law & Regulation1 week ago
FDA to weigh safety, impact of MDMA therapy for PTSD at June meeting
-
Psychedelics1 week ago
MindMed Reports First Quarter 2024 Financial Results and Business Updates
-
Psychedelics1 week ago
Oprah Daily’s Comprehensive Guide to Psychedelics: A Milestone for Industry Acceptance
-
Law & Regulation1 week ago
Compass Pathways keeps plugging away with its psilocybin study trials
-
Psychedelics1 week ago
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic Research
-
Psychedelics1 week ago
The Onion Pokes Fun at Psychedelics
-
Psilocybin1 week ago
Oregon authorities give Kaya Holdings license for psilocybin treatment clinic